TITLE

Manifestări extraintestinale în bolile inflamatorii intestinale - provocări vechi Şi terapii noi

AUTHOR(S)
VOIOSU, THEODOR; GIURCAN, ROXANA; ZAHIU, CARMEN; VOIOSU, RADU
PUB. DATE
December 2010
SOURCE
Romanian Journal of Medical Practice;2010, Vol. 5 Issue 4, p251
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Intestinal inflammatory diseases (IID), represented by ulcerative colitis (UC) and Crohn's Disease, are now considered systemic pathologies with manifestations mainly digestive. Among intestinal inflammatory diseases, there must be made a difference between extra intestinal manifestations and the complications of the disease or treatment. Almost any organ can be interested, especially the eyes, skin, articulations, kidneys, liver with the billiary tract and the vascular system.
ACCESSION #
57494191

 

Related Articles

  • Ulcerative colitis and Crohn's disease. Ferguson, Anne // BMJ: British Medical Journal (International Edition);8/6/94, Vol. 309 Issue 6951, p355 

    Focuses on ulcerative colitis and Crohn's disease. Features of the two diseases; Impact of the medical treatment to the ulceration and fibrosis; Relevance of bowel function and disease.

  • New steroids for IBD: progress report. Hanauer, S.B. // Gut;Aug2002, Vol. 51 Issue 2, p182 

    Discusses the improvement of therapies for ulcerative colitis and Crohn's disease. Absorption efficiency of budenoside; Potency of non-systemic steroids; Efficacy of controlled release formulations.

  • A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient. Wasan, Sharmeel K.; Baker, Stacey E.; Skolnik, Paul R.; Farraye, Francis A. // American Journal of Gastroenterology;Jun2010, Vol. 105 Issue 6, p1231 

    The increasing use of corticosteroids, immune modulators, and biologics as a mainstay of therapy in certain Crohn's disease and ulcerative colitis patients have placed these inflammatory bowel disease (IBD) patients at increased risk for a variety of infections, many of which are preventable by...

  • When do we dare to stop biological or immunomodulatory therapy for Crohn's disease? Results of a multidisciplinary European expert panel. Balzola, Federico; Cullen, Garret; Ho, Gwo-Tzer; Russell, Richard K. // Inflammatory Bowel Disease Monitor;2013, Vol. 14 Issue 1, p20 

    The article focuses on the study that determines the effectiveness of biologics in treating Crohn's disease. It notes the meeting of multidisciplinary European expert panel in 2007 which discusses the withdrawal of biologic treatment of the condition. It also mentions the findings of the studies...

  • Quieting storms: New therapies target IBD, GERD. Guthrie, Ellen Whipple // Pharmacy Today;Jul2005, Vol. 11 Issue 7, p1 

    This article presents information about studies on inflammatory bowel disease (IBD) and gastroesophageal reflux disease therapy. IBDs such as ulcerative colitis and Crohn's disease affect more than 1 million Americans and lead to millions of dollars of lost productivity each year. Preliminary...

  • Maintenance treatment of IBD: patient adherence and current practice. Greveson, Kay // Gastrointestinal Nursing;Jul2008, Vol. 6 Issue 6, p18 

    Crohn's disease and ulcerative colitis or inflammatory bowel disease (IBD) are idiopathic diseases characterised by inflammation and ulceration of the lining of the intestine. Peak incidence is between ten and 40 years but IBD can affect people of any age. Diarrhoea, rectal bleeding and...

  • Interleukin (IL)-1 Gene Cluster in Inflammatory Bowel Disease: Is IL-1RA Implicated in the Disease Onset and Outcome? Muro, Manuel; Mrowiec, Anna // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1126 

    No abstract available.

  • Predictors of Health-Related Quality of Life and Adherence in Crohn's Disease and Ulcerative Colitis: Implications for Clinical Management. Tabibian, Anilga; Tabibian, James; Beckman, Linda; Raffals, Laura; Papadakis, Konstantinos; Kane, Sunanda // Digestive Diseases & Sciences;May2015, Vol. 60 Issue 5, p1366 

    Background and Aims: Inflammatory bowel disease (IBD) is associated with impaired health-related quality of life (HRQOL) and adherence. Our aim was to identify demographic, clinical, and psychosocial predictors of impaired HRQOL and non-adherence to provider recommendations. Methods: Adults with...

  • Colitis and Irritable Bowel. Khalsa, Karta Purkh Singh // Oriental Medicine Journal;Aug2004, Vol. 12 Issue 5, p30 

    The article discusses bowel diseases, including ulcerative colitis, Crohn's disease and irritable bowel syndrome (IBS). Inflammatory bowel disease is the term for a cluster of chronic disorders marked by inflammation or ulceration in the small and large intestines. Ulcerative colitis causes...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics